Previous 10 | Next 10 |
2023-05-13 19:43:05 ET agilon health, inc. (AGL) Q1 2023 Results Conference Call May 09, 2023 04:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Lisa Gill - JPMorgan George Hil...
2023-05-09 16:50:31 ET agilon health press release ( NYSE: AGL ): Q1 GAAP EPS of $0.04 beats by $0.02 . Revenue of $1.14B (+74.6% Y/Y) beats by $60M . Total members live on the agilon platform increased to 490,900 as of March 31, 2023, including 402,200 Medicar...
Revenue increased 74% to $1.14 billion and Medicare Advantage membership increased 61% to 402,200 Total members live on the agilon platform grew to 490,900, including 402,200 Medicare Advantage members and 88,700 ACO REACH beneficiaries Continued gains in profitability dri...
Network members will utilize agilon and Catalyst’s combined expertise and innovation to expand value-based care to more seniors across Texas and accelerate care transformation . Catalyst Health Network , the largest clinically integrated network for independent primary ca...
Preliminary Results for the year ended 31 December 2022 FDA CLEARANCE A MAJOR BREAKTHROUGH FOR PARSORTIX LIQUID BIOPS Parsortix system substantially out-performs standard of care for ovarian cancer diagnosis Prostate cancer partnership signed with Solaris Health Pipeline of op...
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2023 after the market closes on Tuesday, May 9, 2023, and host a conference call at 4:30 PM Eastern Ti...
(NewsDirect) ANGLE PLC (AIM:AGL, OTCQX:ANPCY) chief executive Andrew Newland joins Thomas Warner from Proactive after announcing a development partnership with BioView. The partnership will see the two firms develop to create a circulating tumour cell (CTC) HER2 assay for breast cance...
PARSORTIX POSTER PRESENTED AT AACR ANNUAL MEETING 2023 Study demonstrates the feasibility of combining IF and HER2 FISH analysis with CTCs harvested using the Parsortix system Capability to measure HER2 protein overexpression on CTCs using ANGLE's Portrait Flex assay opens up substantia...
2023-04-06 00:55:53 ET Summary agilon health hosted its 2023 investor day, with positive updates on new health system partnerships and favorable updates to 2026 targets. Post the investor day, I have further conviction on AGL's value proposition. With the CMS rates now finaliz...
Notice of Preliminary Results and Webcast GUILDFORD, SURREY / ACCESSWIRE / April 3, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, will be releasing its preliminary results for the year ended 31 December 2022 on Friday 21 April 2023. A virtual meeting and we...
News, Short Squeeze, Breakout and More Instantly...
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2024 after the market closes on Tuesday, August 6, 2024, and host a conference call at 4:30 PM Easter...
Dr. Rao to Continue to Lead Clinical Strategy and Drive Physician Network Performance Alongside agilon’s Chief Clinical Officer Kevin Spencer, M.D. agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced ...
2024-07-07 00:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...